Lisa Casanova

Dr. Lisa Casanova


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2011 in American Journal of Infection Control
Verified
Journal Article
Closed access
RHRachel L. Hulkower
Rachel L. Hulkower
LCLisa Casanova
Lisa Casanova
WRWilliam A. Rutala
William A. Rutala
DWDavid J. Weber
David J. Weber
MSMark D. Sobsey
Mark D. Sobsey

1 May 2012 in American Journal of Infection Control
Verified
Journal Article
Closed access
LCLisa Casanova
Lisa Casanova
WRWilliam A. Rutala
William A. Rutala
DWDavid J. Weber
David J. Weber
MSMark D. Sobsey
Mark D. Sobsey

22 February 2016 in Environmental Technology
Verified
Journal Article
Closed access
KSKari A. Sholtes
Kari A. Sholtes
KLKincaid Lowe
Kincaid Lowe
GWGlenn W. Walters
Glenn W. Walters
MSMark D. Sobsey
Mark D. Sobsey
KLKarl G. Linden
Karl G. Linden
LCLisa Casanova
Lisa Casanova
Ultraviolet (UV) light-emitting diodes (LEDs) emitting at 260 nm were evaluated to determine the inactivation kinetics of bacteria, viruses, and spores compared to low-pressure (LP) UV irradiation. Test microbes were Escherichia coli B, a non-enveloped virus (MS-2), and a bacterial spore (Bacillus atrophaeus). For LP UV, 4-log10 reduction doses were: E. coli B, 6.5 mJ/cm2; MS-2, 59.3 mJ/cm2; and B. atrophaeus, 30.0 mJ/cm2. For UV LEDs, the 4-log10 reduction doses were E. coli B, 6.2 mJ/cm2; MS-2, 58 mJ/cm2; and B. atrophaeus, 18.7 mJ/cm2. Microbial inactivation kinetics of the two UV technologies were not significantly different for E. coli B and MS-2, but were different for B. atrophaeus spores. UV LEDs at 260 nm are at least as effective for inactivating microbes in water as conventional LP UV sources and should undergo further development in treatment systems to disinfect drinking water.

14 February 2019 in Journal of Water and Health
Verified
Journal Article
Open access
PDF file
ASAmpai Soros
Ampai Soros
JAJames E. Amburgey
James E. Amburgey
CSChristine E. Stauber
Christine E. Stauber
MSMark D. Sobsey
Mark D. Sobsey
LCLisa Casanova
Lisa Casanova
Turbidity reduction by coagulation-flocculation in drinking water reduces microbes and organic matter, increasing effectiveness of downstream treatment. Chitosan is a promising household water coagulant, but needs parameters for use. This study tested the effects of chitosan dose, molecular weight (MW), degree of deacetylation (DD), and functional groups on bentonite and kaolinite turbidity reduction in model household drinking water. Higher MW or DD produced greater reductions. Highest reductions were at doses 1 and 3 mg/L by MW >50,000 or >70% DD (residual turbidity <5 NTU). Higher doses did not necessarily continually increase reduction. For functional groups, 3 mg/L produced the highest reductions by lactate, acetate, and HCl, and lower reductions of kaolinite than bentonite. Doses where the point of zero charge was observed clustered around 3 mg/L. Chitosan reduced clay turbidity in water; effectiveness was influenced by dose, clay type, MW, DD, and functional groups. Reduction did not necessarily increase with MW. Bentonite had a broader effective dose range and higher reduction at the optimal dose than kaolinite. Chitosans with and without functional groups performed similarly. The best of the studied doses was 3 mg/L. Chitosans are promising for turbidity reduction in low-resource settings if combined with sedimentation and/or filtration. This article has been made Open Access thanks to the generous support of a global network of libraries as part of the Knowledge Unlatched Select initiative.

1 August 2016 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
LCLisa Casanova
Lisa Casanova
LTLisa J. Teal
Lisa J. Teal
ESEmily E. Sickbert-Bennett
Emily E. Sickbert-Bennett
DADeverick J. Anderson
Deverick J. Anderson
DSDaniel J. Sexton
Daniel J. Sexton
TPThe Cdc Prevention Epicenters Program
The Cdc Prevention Epicenters Program
OBJECTIVE: Ebola virus disease (EVD) places healthcare personnel (HCP) at high risk for infection during patient care, and personal protective equipment (PPE) is critical. Protocols for EVD PPE doffing have not been validated for prevention of viral self-contamination. Using surrogate viruses (non-enveloped MS2 and enveloped Φ6), we assessed self-contamination of skin and clothes when trained HCP doffed EVD PPE using a standardized protocol.METHODS: A total of 15 HCP donned EVD PPE for this study. Virus was applied to PPE, and a trained monitor guided them through the doffing protocol. Of the 15 participants, 10 used alcohol-based hand rub (ABHR) for glove and hand hygiene and 5 used hypochlorite for glove hygiene and ABHR for hand hygiene. Inner gloves, hands, face, and scrubs were sampled after doffing.RESULTS: After doffing, MS2 virus was detected on the inner glove worn on the dominant hand for 8 of 15 participants, on the non-dominant inner glove for 6 of 15 participants, and on scrubs for 2 of 15 participants. All MS2 on inner gloves was observed when ABHR was used for glove hygiene; none was observed when hypochlorite was used. When using hypochlorite for glove hygiene, 1 participant had MS2 on hands, and 1 had MS2 on scrubs.CONCLUSIONS: A structured doffing protocol using a trained monitor and ABHR protects against enveloped virus self-contamination. Non-enveloped virus (MS2) contamination was detected on inner gloves, possibly due to higher resistance to ABHR. Doffing protocols protective against all viruses need to incorporate highly effective glove and hand hygiene agents.Infect Control Hosp Epidemiol 2016;1–6

17 February 2018 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
LCLisa Casanova
Lisa Casanova
KEKimberly Erukunuakpor
Kimberly Erukunuakpor
CKColleen S Kraft
Colleen S Kraft
JMJoel M Mumma
Joel M Mumma
FDFrancis T Durso
Francis T Durso
JJJesse T Jacob
Jesse T Jacob
Personal protective equipment (PPE) protects healthcare workers (HCWs) caring for patients with Ebola virus disease (EVD), and PPE doffing is a critical point for preventing viral self-contamination. We assessed contamination of skin, gloves, and scrubs after doffing Ebola-level PPE contaminated with surrogate viruses: bacteriophages MS2 and Φ6. In a medical biocontainment unit, HCWs (n = 10) experienced in EVD care donned and doffed PPE following unit protocols that incorporate trained observer guidance and alcohol-based hand rub (ABHR). A mixture of Φ6 (enveloped), MS2 (nonenveloped), and fluorescent marker was applied to 4 PPE sites, approximating body fluid viral load (Φ6, 105; MS2, 106). They performed a patient care task, then doffed. Inner gloves, face, hands, and scrubs were sampled for virus, as were environmental sites with visible fluorescent marker. Among 10 HCWs there was no Φ6 transfer to inner gloves, hands, or face; 1 participant had Φ6 on scrubs at low levels (1.4 × 102). MS2 transfer (range, 101–106) was observed to scrubs (n = 2), hands (n = 1), and inner gloves (n = 7), where it was highest. Most (n = 8) had only 1 positive site. Environmental samples with visible fluorescent marker (n = 21) were negative. Among experienced HCWs, structured, observed doffing using ABHR protected against hand contamination with enveloped virus. Nonenveloped virus was infrequent on hands and scrubs but common on inner gloves, suggesting that inner gloves, but not necessarily ABHR, protect against hand contamination. Optimizing doffing protocols to protect against all types of viruses may require reinforcing careful handling of scrubs and good glove/hand hygiene with effective agents.